This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A paper published in the Journal of PharmaceuticalResearch International has reviewed microbiological testing for medical devices and described their applications and challenges. This approach can also help determine the appropriate manufacturing processes, sterilisation methods, and maintenance procedures. Sharma et al.
The exhibition, which will take place from 8-10 October 2024, is being hosted in Milan for the second time in three years in recognition of the massive pharmaceutical ingredients and manufacturing industry in the region. The post CPHI to return to Milan in 2024 appeared first on European Pharmaceutical Review.
Social medias position in pharmaceuticalresearch is further cemented by peoples growing usage of it. Healthcare professionals are also catching up to the patient group, which has long been engaged on social media. It can be applied to comprehend patient difficulties and spot chances for clinical intervention.
percent, a paper published in International Journal of Pharmaceutics: X has shown. This is especially true for additive manufacturing and the production of unique dosage forms and personalised medicines. Using inkjet printing, optimised machine learning (ML) models predicted the printability of drug formulations with an accuracy of 97.22
A new report from the PharmaceuticalResearch and Manufacturers of America (PhRMA) has highlighted the importance of post-approval R&D in advancing oncology treatment options and delivering unprecedented progress over the past ten years. This therefore broadens the population of patients who may benefit.
Key study findings Study results demonstrated that precise control of tablet surface geometry “effectively tailored drug release profiles, enhancing patient compliance and treatment efficacy”. their approach in the study addresses “diverse pharmaceuticalmanufacturing demands”. This paper is published in PharmaceuticalResearch.
Dall talked about GlobalData’s partnership with the trade organisation PharmaceuticalResearch and Manufacturers of America (PhRMA), which has allowed for a focused effort to analyse and tackle health equity issues within the United States (US). . trillion in savings over the next decade.
However, there is a high level of attrition during the pharmaceuticalresearch and development process, which is an indicator of the vast number of potential drug substances considered for progression. Therefore, it is vital to choose molecules for pharmaceutical development very carefully.
From new legislation to functional shifts in marketing and advertising, the pharma industry works hard every day to keep up with new regulatory requirements and the constantly evolving expectations of prescribers and patients. – Increased Caution From Patients & Prescribers. – New & Updated Legislation.
We’re gaining a richer understanding of the brain’s complex inner workings, and today’s innovations reveal the vast, untapped potential of science and technology to transform the lives of patients and their families. Regarding leadership, my guiding principle has always been to do what’s right for patients and your people.
Merith Basey, the executive director of the advocacy group Patients for Affordable Drugs, said that CMS’s lack of negotiating power is a key reason that US patients pay up to four times as much for drugs as patients in other countries.
In pharmaceuticalresearch, this may help secure the privacy of patient data used by AI systems and decrease bias due to ethnicity, sex and other factors. This strategy and the new standards made from it, aim to improve privacy standards for any data used by AI technology and reduce biases that may arise from data.
It has boosted anti-tumour research by 60% since 2005, at a cost of $1.6bn, in the hope of increasing the share of company sales attributed to cancer drugs from the current level of 5% “There are a lot of patients that are suffering,” said Pfizer chief executive Jeffrey Kindler.
One of the biggest problems with a system that directs medical research towards profits rather than needs is that R&D funding is channelled to those products that can make pharma companies the most money. The best prospects are drugs targeted at patients who are high-value and who will use the drugs long term.
The PharmaceuticalResearch and Manufacturers of America raised nearly $527 million last year and spent roughly $506 million, new tax returns obtained by OpenSecrets reveal. That’s a record haul for the organization, which is funded by the world’s most powerful pharmaceutical companies.
The PharmaceuticalResearch and Manufacturers of America (PhRMA) was quick to denounce the bill, sending a letter to all 100 senators which argues in strong terms that the bill will hurt pharmaceutical innovation. “That’s not negotiation, it’s government price setting. .
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content